Published in Ageing Res Rev on October 01, 2010
Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation. PLoS One (2013) 1.06
Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging (2012) 1.04
Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets. J Virol (2012) 0.95
Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response? Nutrients (2015) 0.87
Reversing T cell immunosenescence: why, who, and how. Age (Dordr) (2012) 0.85
The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol (2013) 0.85
Immunological hurdles of ageing: indispensable research of the human model. Ageing Res Rev (2011) 0.84
Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza. Viruses (2012) 0.82
The Avalanche is Coming … And Just Now It's Starting to Snow. Front Immunol (2013) 0.82
How important is vitamin D in preventing infections? Osteoporos Int (2012) 0.82
Aging and neoteny in the B lineage. Blood (2012) 0.81
Effect of the conditional cash transfer program Oportunidades on vaccination coverage in older Mexican people. BMC Int Health Hum Rights (2013) 0.79
Influenza vaccination in the face of immune exhaustion: is herd immunity effective for protecting the elderly? Influenza Res Treat (2012) 0.79
Aging adults and seasonal influenza: does the vitamin d status (h)arm the body? J Aging Res (2011) 0.78
Influenza vaccination in the elderly: why are the overall benefits still hotly debated? J Prev Med Hyg (2015) 0.77
CpG Improves Influenza Vaccine Efficacy in Young Adult but Not Aged Mice. PLoS One (2016) 0.75
Frequent Isolations of Influenza A Viruses (H1N1)pdm09 with Identical Hemagglutinin Sequences for More Than Three Months in Japan. Yonago Acta Med (2015) 0.75
Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial. PLoS One (2016) 0.75
Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance. Influenza Other Respir Viruses (2015) 0.75
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet (2009) 4.07
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr (2009) 2.80
B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood (2008) 2.44
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) (2010) 2.33
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med (2003) 2.19
Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol (2011) 2.17
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol (2002) 1.98
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood (2007) 1.85
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr (2007) 1.77
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum (2011) 1.67
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses. J Immunol (2012) 1.59
Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med (2005) 1.48
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med (2010) 1.45
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. Vaccine (2004) 1.36
Influenza control in the 21st century: Optimizing protection of older adults. Vaccine (2009) 1.34
Intracellular adhesion molecule 1 plays a key role in acquired immunity to salmonellosis. Infect Immun (2003) 1.32
Impaired antibody response causes persistence of prototypic T cell-contained virus. PLoS Biol (2009) 1.31
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy. J Infect Dis (2010) 1.27
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis (2008) 1.26
Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol (2002) 1.24
CMV and Immunosenescence: from basics to clinics. Immun Ageing (2012) 1.17
CD25-expressing CD8+ T cells are potent memory cells in old age. J Immunol (2005) 1.16
Early immunological development and mortality from infectious disease in later life. Proc Nutr Soc (2006) 1.16
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health (2004) 1.15
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics (2005) 1.13
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J Immunol (2006) 1.12
Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan. Trop Med Int Health (2006) 1.11
Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis (2012) 1.09
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvant. PLoS One (2008) 1.08
Glycoconjugate vaccines and immune interference: A review. Vaccine (2010) 1.07
Immunosenescence: Implications for vaccination programmes in adults. Maturitas (2011) 1.07
Improved thymic function in exclusively breastfed infants is associated with higher interleukin 7 concentrations in their mothers' breast milk. Am J Clin Nutr (2004) 1.07
Acceptability of maternal immunization against influenza: the critical role of obstetricians. J Matern Fetal Neonatal Med (2012) 1.06
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect Immun (2002) 1.05
Vaccination during pregnancy to protect infants against influenza: why and why not? Vaccine (2011) 1.05
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants. J Infect Dis (2006) 1.04
Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence. Clin Interv Aging (2012) 1.04
Booster vaccination after neonatal priming with acellular pertussis vaccine. J Pediatr (2010) 1.02
Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat (2004) 1.02
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice. J Immunol (2004) 1.00
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice. Infect Immun (2002) 0.99
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants. J Immunol (2012) 0.99
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. J Control Release (2012) 0.98
The next decade of vaccines: societal and scientific challenges. Lancet (2011) 0.97
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS One (2009) 0.96
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory? Vaccine (2010) 0.95
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell niche. J Immunol (2012) 0.95
Neonatal immunization: where do we stand? Curr Opin Infect Dis (2011) 0.95
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infection. J Infect Dis (2002) 0.95
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells. Eur J Immunol (2008) 0.95
Molecular quantitation of thymic output in mice and the effect of IL-7. Eur J Immunol (2002) 0.94
An IL-7 fusion protein that shows increased thymopoietic ability. J Immunol (2005) 0.94
A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene. Cancer Res (2004) 0.94
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Pediatr Infect Dis J (2013) 0.93
Thymic output, ageing and zinc. Biogerontology (2006) 0.90
Mode of action of adjuvants: implications for vaccine safety and design. Biologicals (2010) 0.89
Vaccine safety controversies and the future of vaccination programs. Pediatr Infect Dis J (2005) 0.89
The advantage of mucosal immunization for polysaccharide-specific memory responses in early life. Eur J Immunol (2005) 0.89
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. Vaccine (2011) 0.89
Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand. Br J Haematol (2003) 0.88
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles. Virology (2003) 0.88
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia. Pharmacogenomics (2011) 0.87
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. Eur J Immunol (2006) 0.87
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium). Vaccine (2003) 0.86
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheres. J Immunol (2004) 0.86
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children. Pediatr Infect Dis J (2013) 0.85
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. Haematologica (2011) 0.85
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers. J Immunol (2003) 0.85
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. J Virol (2007) 0.85
Reversing T cell immunosenescence: why, who, and how. Age (Dordr) (2012) 0.85
Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules? Expert Rev Vaccines (2012) 0.85
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection? Clin Vaccine Immunol (2006) 0.84
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-up. J Trauma (2007) 0.84
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate. Vaccine (2003) 0.84
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys. Am J Trop Med Hyg (2004) 0.83
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines. Eur J Immunol (2002) 0.83
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in Switzerland. Pediatr Infect Dis J (2009) 0.83
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr (2004) 0.83
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune). AIDS Res Hum Retroviruses (2003) 0.81
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measures. Scand J Infect Dis (2010) 0.81
Comparison of manual and automated DNA purification for measuring TREC in dried blood spot (DBS) samples with qPCR. J Immunol Methods (2012) 0.81
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infants. J Pediatr (2008) 0.81
Long-term effects of perinatal nutrition on T lymphocyte kinetics in young Gambian men. Am J Clin Nutr (2007) 0.81
Immune senescence and vaccination in the elderly. Curr Top Med Chem (2013) 0.81
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr (2008) 0.81
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young children. J Leukoc Biol (2013) 0.81
Atorvastatin treatment and vaccination efficacy. J Clin Pharmacol (2007) 0.81
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients. Oncologist (2012) 0.81
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? Arch Neurol (2011) 0.81